SYMSFYRE Trademark

Trademark Overview


On Thursday, May 12, 2022, a trademark application was filed for SYMSFYRE with the United States Patent and Trademark Office. The USPTO has given the SYMSFYRE trademark a serial number of 97408277. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 22, 2024. This trademark is owned by AstraZeneca AB. The SYMSFYRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
symsfyre

General Information


Serial Number97408277
Word MarkSYMSFYRE
Filing DateThursday, May 12, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events


Event DateEvent Description
Monday, May 16, 2022NEW APPLICATION ENTERED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO EXAMINER
Tuesday, December 13, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 3, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, March 3, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 7, 2023ASSIGNED TO LIE
Tuesday, November 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 22, 2024SOU EXTENSION 1 GRANTED
Monday, July 22, 2024SOU EXTENSION 1 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED